Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinosarcoma × Gemcitabine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 367 Carcinoma, Non-Small-Cell Lung 124 Breast Neoplasms 76 Urinary Bladder Neoplasms 74 Lung Neoplasms 70 Cholangiocarcinoma 69 Neoplasm Metastasis 56 Neoplasms 53 Nasopharyngeal Carcinoma 50 Biliary Tract Neoplasms 48 Ovarian Neoplasms 39 Sarcoma 38 Recurrence 35 Gallbladder Neoplasms 35 Hodgkin Disease 34 Lymphoma, Large B-Cell, Diffuse 31 Lymphoma 31 Carcinoma, Transitional Cell 27 Bile Duct Neoplasms 20 Adenocarcinoma 19 Lymphoma, Non-Hodgkin 17 Fallopian Tube Neoplasms 17 Carcinoma, Hepatocellular 16 Non-Muscle Invasive Bladder Neoplasms 15 Carcinoma 15 Adenocarcinoma of Lung 15 Triple Negative Breast Neoplasms 14 Liver Neoplasms 14 Leiomyosarcoma 14 Lymphoma, Extranodal NK-T-Cell 13

Interventions

Specimen Handling 3 Paclitaxel 3 Nivolumab 3 olaparib 2 X-Rays 2 Carboplatin 2 Biopsy 2 sargramostim 1 pembrolizumab 1 pazopanib 1 pamiparib 1 durvalumab 1 ceralasertib 1 cediranib 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Minimally Invasive Surgical Procedures 1 Magnetic Resonance Spectroscopy 1 LY-2157299 1 Indocyanine Green 1 Immunoglobulin G 1 Gemcitabine 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Cisplatin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡